Mechanisms of staphylococcal skin colonization

Information

  • Research Project
  • 10449721
  • ApplicationId
    10449721
  • Core Project Number
    R56AI162964
  • Full Project Number
    1R56AI162964-01
  • Serial Number
    162964
  • FOA Number
    PA-20-185
  • Sub Project Id
  • Project Start Date
    9/15/2021 - 3 years ago
  • Project End Date
    8/31/2022 - 2 years ago
  • Program Officer Name
    HUNTLEY, CLAYTON C
  • Budget Start Date
    9/15/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    9/15/2021 - 3 years ago

Mechanisms of staphylococcal skin colonization

ABSTRACT The goal of this Multi-PI project is to understand how Staphylococcus spp. bind to the skin surface. Although S. aureus has the capability to cause significant disease in humans, most Staphylococcus spp. do not cause disease but instead act as commensals or mutualists and adhere to the skin surface providing beneficial aspects to the host. These benefits include inhibition of pathogen colonization by synthesis of unique antimicrobial compounds in addition to appropriate immune system development. However, we do not know how Staphylococcus spp adhere to skin. This application hypothesizes that species of staphylococci that colonize humans do so in a conserved manner via an Aap (or SasG in S. aureus) orthologue that binds corneocytes. Aap is a rod-like fibrillar protein that functions in initial adherence to corneocytes but also functions to mediate intercellular accumulation. To address this hypothesis, we have proposed the following specific aims: (1) understand the dynamics of Aap-mediated corneocyte adherence; (2) define the ligand specificity of Aap and SasG lectin domains and (3) investigate S. aureus SasG-dependent mechanisms of skin colonization. Overall, the proposed studies will address how staphylococci bind to skin, what ligand is bound, and thus could uncover new layers of crosstalk between pathogen and the host, potentially leading to novel therapeutic modalities for treating staphylococcal infections.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R56
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
    549908
  • Indirect Cost Amount
    100788
  • Total Cost
    650696
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIAID:650696\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    BACP
  • Study Section Name
    Bacterial Pathogenesis Study Section
  • Organization Name
    UNIVERSITY OF NEBRASKA MEDICAL CENTER
  • Organization Department
    PATHOLOGY
  • Organization DUNS
    168559177
  • Organization City
    OMAHA
  • Organization State
    NE
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    681987835
  • Organization District
    UNITED STATES